

Colgate-Palmolive vs Kimberly-Clark
Colgate-Palmolive and Kimberly-Clark are examined on this page to compare their business models, financial performance, and market context. The page presents neutral analysis of strategies, operations, and market position to help readers understand how each company operates in the consumer goods sector. Educational content, not financial advice.
Colgate-Palmolive and Kimberly-Clark are examined on this page to compare their business models, financial performance, and market context. The page presents neutral analysis of strategies, operations...
Why It's Moving

Colgate-Palmolive dips amid consumer staples caution as options volatility signals choppy trading ahead.
- Stock fell from $77.74 to $77.25 on Thursday, continuing a pattern of recent declines with lower trading volume hinting at fading momentum.
- Implied volatility spiked for Dec. 19 $35 calls, alerting traders to potential sharp moves amid Zacks Rank #4 (Sell) and five downward EPS estimate cuts to $0.92.
- Q2 organic sales grew 1.8% via innovation in oral care and pet nutrition, though full-year guidance trimmed to low-end 2-4% due to pet sales exits and macro headwinds.

Kimberly-Clark sets stage for Q4 earnings reveal amid steady dividend commitment.
- Q4 earnings release slated for January 27 at 6:30 a.m. EST, followed by management Q&A, heightening anticipation for end-of-year insights.
- Board declared $1.26 quarterly dividend payable January 5, 2026—marking 53 straight years of increases and underscoring financial stability.
- Recent quarters showed EPS beats like $1.82 for Q3 (Sep 2025), signaling resilient demand for essentials amid sector headwinds.

Colgate-Palmolive dips amid consumer staples caution as options volatility signals choppy trading ahead.
- Stock fell from $77.74 to $77.25 on Thursday, continuing a pattern of recent declines with lower trading volume hinting at fading momentum.
- Implied volatility spiked for Dec. 19 $35 calls, alerting traders to potential sharp moves amid Zacks Rank #4 (Sell) and five downward EPS estimate cuts to $0.92.
- Q2 organic sales grew 1.8% via innovation in oral care and pet nutrition, though full-year guidance trimmed to low-end 2-4% due to pet sales exits and macro headwinds.

Kimberly-Clark sets stage for Q4 earnings reveal amid steady dividend commitment.
- Q4 earnings release slated for January 27 at 6:30 a.m. EST, followed by management Q&A, heightening anticipation for end-of-year insights.
- Board declared $1.26 quarterly dividend payable January 5, 2026—marking 53 straight years of increases and underscoring financial stability.
- Recent quarters showed EPS beats like $1.82 for Q3 (Sep 2025), signaling resilient demand for essentials amid sector headwinds.
Which Baskets Do They Appear In?
Resilience In The Aisles: Consumer Staples
A recent survey shows U.S. consumer sentiment has fallen due to persistent inflation, reaching its lowest point in four months. This theme focuses on consumer staples companies, which tend to remain stable as households prioritize essential goods over discretionary purchases.
Published: August 17, 2025
Explore BasketMarket Fear
When markets get shaky, these stocks stand strong. Our professional analysts have carefully selected companies known for their stability during uncertain times, focusing on essential goods and services that people need regardless of economic conditions.
Published: June 18, 2025
Explore BasketMarket Indecision
Find refuge from market volatility with these carefully selected companies providing essential goods and services. Our professional analysts have handpicked high-quality, dividend-paying stocks in defensive sectors that offer stability when economic futures look uncertain.
Published: June 18, 2025
Explore BasketWhich Baskets Do They Appear In?
Resilience In The Aisles: Consumer Staples
A recent survey shows U.S. consumer sentiment has fallen due to persistent inflation, reaching its lowest point in four months. This theme focuses on consumer staples companies, which tend to remain stable as households prioritize essential goods over discretionary purchases.
Published: August 17, 2025
Explore BasketMarket Fear
When markets get shaky, these stocks stand strong. Our professional analysts have carefully selected companies known for their stability during uncertain times, focusing on essential goods and services that people need regardless of economic conditions.
Published: June 18, 2025
Explore BasketMarket Indecision
Find refuge from market volatility with these carefully selected companies providing essential goods and services. Our professional analysts have handpicked high-quality, dividend-paying stocks in defensive sectors that offer stability when economic futures look uncertain.
Published: June 18, 2025
Explore BasketInvestment Analysis
Pros
- Colgate-Palmolive's revenue increased by over 3% in 2024 to $20.1 billion, showing steady top-line growth.
- The company has a strong dividend yield of approximately 2.7%, providing consistent income to investors.
- Colgate-Palmolive benefits from a diversified product portfolio spanning oral care, personal care, home care, and pet nutrition.
Considerations
- The stock trades at a relatively high price-to-earnings ratio around 21.5, which may indicate overvaluation versus peers.
- Colgate-Palmolive has a higher debt-to-equity ratio that could imply greater financial leverage risks.
- The company's stock price has shown limited appreciation over the past year, suggesting growth limitations in current market conditions.
Pros
- Kimberly-Clark is ranked highly on fundamental stock indicators, reflecting strong financial health and operational performance.
- The company has moderate correlation with Colgate-Palmolive, offering potential portfolio diversification benefits.
- Kimberly-Clark maintains a solid market capitalization near $44 billion, supporting its stable industry position.
Considerations
- Kimberly-Clark’s year-to-date and annual stock performance have been lower compared to Colgate-Palmolive, indicating weaker recent momentum.
- The stock shows moderate beta and volatility, which may lead to higher risk than more defensive consumer staple peers.
- Limited recent growth catalysts have constrained Kimberly-Clark’s ability to outpace competitors in consumer goods.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons


Colgate-Palmolive vs Kroger
Colgate-Palmolive vs Kroger stock comparison


Colgate-Palmolive vs Diageo
Colgate-Palmolive vs Diageo: a quick comparison


Colgate-Palmolive vs Ambev
Colgate-Palmolive vs Ambev